IS6932A - Ört uppleysanlegar töflur sýklóoxýgenasa-3 ensímhindra - Google Patents

Ört uppleysanlegar töflur sýklóoxýgenasa-3 ensímhindra

Info

Publication number
IS6932A
IS6932A IS6932A IS6932A IS6932A IS 6932 A IS6932 A IS 6932A IS 6932 A IS6932 A IS 6932A IS 6932 A IS6932 A IS 6932A IS 6932 A IS6932 A IS 6932A
Authority
IS
Iceland
Prior art keywords
cyclooxygenase
enzyme inhibitor
highly soluble
inhibitor tablets
tablets
Prior art date
Application number
IS6932A
Other languages
English (en)
Inventor
Murpani Deepak
Original Assignee
Ranbaxy Laboratories Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Laboratories Limited filed Critical Ranbaxy Laboratories Limited
Publication of IS6932A publication Critical patent/IS6932A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IS6932A 2001-02-27 2003-08-27 Ört uppleysanlegar töflur sýklóoxýgenasa-3 ensímhindra IS6932A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN189DE2001 2001-02-27
PCT/IB2002/000587 WO2002067894A2 (en) 2001-02-27 2002-02-27 Fast dissolving tablets of cyclooxygenase-2 enzyme inhibitors

Publications (1)

Publication Number Publication Date
IS6932A true IS6932A (is) 2003-08-27

Family

ID=11097035

Family Applications (1)

Application Number Title Priority Date Filing Date
IS6932A IS6932A (is) 2001-02-27 2003-08-27 Ört uppleysanlegar töflur sýklóoxýgenasa-3 ensímhindra

Country Status (9)

Country Link
EP (1) EP1367994A2 (is)
AU (1) AU2002236120A1 (is)
CZ (1) CZ20032568A3 (is)
HU (1) HUP0400098A2 (is)
IS (1) IS6932A (is)
OA (1) OA12686A (is)
PL (1) PL363771A1 (is)
SK (1) SK11802003A3 (is)
WO (1) WO2002067894A2 (is)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7815937B2 (en) 1998-10-27 2010-10-19 Biovail Laboratories International Srl Quick dissolve compositions and tablets based thereon
CN1638739A (zh) * 2000-08-18 2005-07-13 法玛西雅厄普约翰美国公司 治疗成瘾性障碍的化合物
TR200301552A1 (tr) * 2003-09-18 2005-10-21 Nobel İlaç Sanayi̇ Ve Ti̇caret A. Ş. Rofekoksib' in yeni oral farmakolojik formülasyonları.
GB0724707D0 (en) * 2007-12-19 2008-01-30 Burke Michael H A process for the preparation of an orally administered unit dose tablet
US10350171B2 (en) 2017-07-06 2019-07-16 Dexcel Ltd. Celecoxib and amlodipine formulation and method of making the same
CN108653225B (zh) * 2018-08-15 2021-01-08 湖北舒邦药业有限公司 一种尼美舒利制剂及其制备方法
CN112569178B (zh) * 2020-12-29 2022-09-09 南京百泽医药科技有限公司 一种帕瑞昔布药物组合物制备方法及用作舌下制剂的用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA964928B (en) * 1995-06-13 1997-12-10 American Home Prod Oral formulations of S(+)-etodolac.
EP0945134A1 (de) * 1998-03-27 1999-09-29 Boehringer Ingelheim Pharma KG Neue galenische Zubereitungsformen von Meloxicam zur oralen Applikation
WO2001085134A1 (en) * 2000-05-12 2001-11-15 Emcure Pharmaceuticals Ltd Pharmaceutical solid compositions and process for the production of mouth dissolving tablets

Also Published As

Publication number Publication date
HUP0400098A2 (hu) 2004-04-28
SK11802003A3 (sk) 2004-06-08
AU2002236120A1 (en) 2002-09-12
PL363771A1 (en) 2004-11-29
EP1367994A2 (en) 2003-12-10
OA12686A (en) 2006-06-21
WO2002067894A2 (en) 2002-09-06
WO2002067894A3 (en) 2002-12-19
CZ20032568A3 (cs) 2004-04-14

Similar Documents

Publication Publication Date Title
DE60002193T2 (de) Metalloprotease inhibitoren
CY2015028I1 (el) Ενας αναστολεας ν-ακυλοσφιγγοσινο γλυκοζυλοτρανσφερασης
CY2012007I1 (el) Πεπτιδομιμητικοι αναστολεις πρωτεασης
DE60234125D1 (de) E inhibitoren
ATE286049T1 (de) Pyridazinonaldose reductase inhibitoren
DE60211317D1 (de) Rho-kinase inhibitoren
DE60218138D1 (de) Rho-kinase inhibitoren
NO20034045D0 (no) Metallproteinase-inhibitorer
ATE524441T1 (de) Vla-4-inhibitoren
NO20034032L (no) Metallproteinase-inhibitorer
DK1272488T3 (da) Tri-aryl-substitueret ethan-PDE4-inhibitorer
NO20014243D0 (no) Dihetero-substituerte metalloprotease inhibitorer
PT1171440E (pt) 3-ciano-¬1,7|,¬1,5|, e ¬1,8|-naftiridinas substituidas inibidoras de tirosina quinases
NO20025786L (no) Protaseinhibitorer
DE60024101D1 (de) Enzyminhibitoren
IS6932A (is) Ört uppleysanlegar töflur sýklóoxýgenasa-3 ensímhindra
PT1339695E (pt) Inibidores da farnesiltransferase
NO20024481D0 (no) Difluorbutyrsyre metalloproteaseinhibitorer
NO20025005D0 (no) Proteaseinhibitorer
NO20032328L (no) Proteaseinhibitorer
FI20002015A (fi) Kuparia sisältävien amiinioksidaasien inhibiittorit
FI20002561A0 (fi) Haketusterä
FI20012221A0 (fi) Haketusterä
IDP000027420A (id) Inhibitor-inhibitor kinase pirolotriazin
GB0104691D0 (en) Enzyme inhibitor